Analysts raised questions about the sustainability of positive pricing trends and the ability to ramp up new product launches effectively. Zimmer Biomet delivered solid Q4 2024 results ...

As part of its scheme, Zimmer has offered to enter into asset purchase agreements with most of Biomet s distributors. Demonstrating the strength of Biomet s products and relationships ...

Equities researchers at Zacks Research cut their Q1 2025 earnings per share (EPS) estimates for Zimmer Biomet in a report ...

NeuroOne achieved record product sales of $3.3 million in Q1, driven by its partnership with Zimmer Biomet. Total quarterly revenue reached $6.3 million, including a $3 million upfront license ...

Three months after becoming Zimmer Biomet’s chief movement officer ... The manufacturer of orthopedic medtech products finally showed its hand Wednesday, inviting people with joint pain to ...

WARSAW, Ind., Feb. 25, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced upcoming changes to the Company's Board of ...

Zimmer Biomet is a global medical technology leader ... We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies ...

Feb. 27, 2025 /PRNewswire/ -- Zimmer Biomet Holdings ... In addition, he will have oversight of the research and product development organizations, inclusive of new product and service development ...

Zimmer Biomet Holdings, Inc, together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products ...

Forward-looking statements include, but are not limited to, statements concerning Zimmer Biomet's expectations, plans, prospects, and product and service offerings. Such statements are based upon ...